Bethany Powell Gray

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Inflammatory Response

Neuropathic Pain

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Ou-Yang Chen, Chang-Yu Jiang, Temugin Berta, Bethany Powell Gray, Kenta Furutani, Bruce A Sullenger, Ru-Rong Ji
MicroRNA let-7b enhances spinal cord nociceptive synaptic transmission and induces acute and persistent pain through neuronal and microglial signaling. Pain 165 (8) (2024)
Ou-Yang Chen, Chang-Yu Jiang, Temugin Berta, Bethany Powell Gray, Kenta Furutani, Bruce A Sullenger, Ru-Rong Ji
MicroRNA let-7b enhances spinal cord nociceptive synaptic transmission and induces acute and persistent pain through neuronal and microglial signaling. Pain 165 (8) (2024)
Ou-Yang Chen, Chang-Yu Jiang, Temugin Berta, Bethany Powell Gray, Kenta Furutani, Bruce A Sullenger, Ru-Rong Ji
MicroRNA let-7b enhances spinal cord nociceptive synaptic transmission and induces acute and persistent pain through neuronal and microglial signaling. Pain 165 (8) (2024)
Ou-Yang Chen, Chang-Yu Jiang, Temugin Berta, Bethany Powell Gray, Kenta Furutani, Bruce A Sullenger, Ru-Rong Ji
MicroRNA let-7b enhances spinal cord nociceptive synaptic transmission and induces acute and persistent pain through neuronal and microglial signaling. Pain 165 (8) (2024)
Ou-Yang Chen, Chang-Yu Jiang, Temugin Berta, Bethany Powell Gray, Kenta Furutani, Bruce A Sullenger, Ru-Rong Ji
MicroRNA let-7b enhances spinal cord nociceptive synaptic transmission and induces acute and persistent pain through neuronal and microglial signaling. Pain (2024)
Xirui Song, Haixiang Yu, Cynthia Sullenger, Bethany Powell Gray, Amy Yan, Linsley Kelly, Bruce A Sullenger
An Aptamer That Rapidly Internalizes into Cancer Cells Utilizes the Transferrin Receptor Pathway. Cancers 15 (8) (2023)
Xirui Song, Haixiang Yu, Cynthia Sullenger, Bethany Powell Gray, Amy Yan, Linsley Kelly, Bruce A Sullenger
An Aptamer That Rapidly Internalizes into Cancer Cells Utilizes the Transferrin Receptor Pathway. Cancers 15 (8) (2023)